Keyword: insulin treatment
News
11.01.2016
- Sanofi has handed back rights to the inhaled insulin treatment Afrezza to US drug development company MannKind. Sales of Afrezza, which launched in the US in February last year...
News
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...